1,436
Views
28
CrossRef citations to date
0
Altmetric
Report

ERCC1 function in nuclear excision and interstrand crosslink repair pathways is mediated exclusively by the ERCC1-202 isoform

, , , , , , , , , , , , , & show all
Pages 3298-3306 | Received 12 Aug 2013, Accepted 28 Aug 2013, Published online: 09 Sep 2013

References

  • Usanova S, Piée-Staffa A, Sied U, Thomale J, Schneider A, Kaina B, Köberle B. Cisplatin sensitivity of testis tumour cells is due to deficiency in interstrand-crosslink repair and low ERCC1-XPF expression. Mol Cancer 2010; 9:248; http://dx.doi.org/10.1186/1476-4598-9-248; PMID: 20846399
  • Niedernhofer LJ, Odijk H, Budzowska M, van Drunen E, Maas A, Theil AF, de Wit J, Jaspers NG, Beverloo HB, Hoeijmakers JH, et al. The structure-specific endonuclease Ercc1-Xpf is required to resolve DNA interstrand cross-link-induced double-strand breaks. Mol Cell Biol 2004; 24:5776 - 87; http://dx.doi.org/10.1128/MCB.24.13.5776-5787.2004; PMID: 15199134
  • Bhagwat N, Olsen AL, Wang AT, Hanada K, Stuckert P, Kanaar R, D’Andrea A, Niedernhofer LJ, McHugh PJ. XPF-ERCC1 participates in the Fanconi anemia pathway of cross-link repair. Mol Cell Biol 2009; 29:6427 - 37; http://dx.doi.org/10.1128/MCB.00086-09; PMID: 19805513
  • Kikuchi K, Narita T, Pham VT, Iijima J, Hirota K, Keka IS, Mohiuddin, Okawa K, Hori T, Fukagawa T, et al. Structure-specific endonucleases Xpf and Mus81 play overlapping but essential roles in DNA repair by homologous recombination. Cancer Res 2013; 73:4362 - 71; http://dx.doi.org/10.1158/0008-5472.CAN-12-3154; PMID: 23576554
  • Motycka TA, Bessho T, Post SM, Sung P, Tomkinson AE. Physical and functional interaction between the XPF/ERCC1 endonuclease and hRad52. J BiolChem 2004; 279:13634 - 9; http://dx.doi.org/10.1074/jbc.M313779200; PMID: 14734547
  • Al-Minawi AZ, Lee YF, Håkansson D, Johansson F, Lundin C, Saleh-Gohari N, Schultz N, Jenssen D, Bryant HE, Meuth M, et al. The ERCC1/XPF endonuclease is required for completion of homologous recombination at DNA replication forks stalled by inter-strand cross-links. Nucleic Acids Res 2009; 37:6400 - 13; http://dx.doi.org/10.1093/nar/gkp705; PMID: 19713438
  • Al-Minawi AZ, Saleh-Gohari N, Helleday T. The ERCC1/XPF endonuclease is required for efficient single-strand annealing and gene conversion in mammalian cells. Nucleic Acids Res 2008; 36:1 - 9; http://dx.doi.org/10.1093/nar/gkm888; PMID: 17962301
  • McNeil EM, Melton DW. DNA repair endonuclease ERCC1-XPF as a novel therapeutic target to overcome chemoresistance in cancer therapy. Nucleic Acids Res 2012; 40:9990 - 10004; http://dx.doi.org/10.1093/nar/gks818; PMID: 22941649
  • Li L, Elledge SJ, Peterson CA, Bales ES, Legerski RJ. Specific association between the human DNA repair proteins XPA and ERCC1. ProcNatlAcadSci U S A 1994; 91:5012 - 6; http://dx.doi.org/10.1073/pnas.91.11.5012; PMID: 8197174
  • de Laat WL, Appeldoorn E, Sugasawa K, Weterings E, Jaspers NG, Hoeijmakers JH. DNA-binding polarity of human replication protein A positions nucleases in nucleotide excision repair. Genes Dev 1998; 12:2598 - 609; http://dx.doi.org/10.1101/gad.12.16.2598; PMID: 9716411
  • Bessho T, Sancar A, Thompson LH, Thelen MP. Reconstitution of human excision nuclease with recombinant XPF-ERCC1 complex. J BiolChem 1997; 272:3833 - 7; http://dx.doi.org/10.1074/jbc.272.6.3833; PMID: 9013642
  • Fisher LA, Bessho M, Wakasugi M, Matsunaga T, Bessho T. Role of interaction of XPF with RPA in nucleotide excision repair. J MolBiol 2011; 413:337 - 46; http://dx.doi.org/10.1016/j.jmb.2011.08.034; PMID: 21875596
  • Matsunaga T, Park CH, Bessho T, Mu D, Sancar A. Replication protein A confers structure-specific endonuclease activities to the XPF-ERCC1 and XPG subunits of human DNA repair excision nuclease. J BiolChem 1996; 271:11047 - 50; http://dx.doi.org/10.1074/jbc.271.19.11047; PMID: 8626644
  • Wang C, Lambert MW. The Fanconi anemia protein, FANCG, binds to the ERCC1-XPF endonuclease via its tetratricopeptide repeats and the central domain of ERCC1. Biochemistry 2010; 49:5560 - 9; http://dx.doi.org/10.1021/bi100584c; PMID: 20518486
  • Svendsen JM, Smogorzewska A, Sowa ME, O’Connell BC, Gygi SP, Elledge SJ, Harper JW. Mammalian BTBD12/SLX4 assembles a Holliday junction resolvase and is required for DNA repair. Cell 2009; 138:63 - 77; http://dx.doi.org/10.1016/j.cell.2009.06.030; PMID: 19596235
  • Muñoz IM, Hain K, Déclais AC, Gardiner M, Toh GW, Sanchez-Pulido L, Heuckmann JM, Toth R, Macartney T, Eppink B, et al. Coordination of structure-specific nucleases by human SLX4/BTBD12 is required for DNA repair. Mol Cell 2009; 35:116 - 27; http://dx.doi.org/10.1016/j.molcel.2009.06.020; PMID: 19595721
  • Rageul J, Frëmin C, Ezan F, Baffet G, Langouët S. The knock-down of ERCC1 but not of XPF causes multinucleation. DNA Repair (Amst) 2011; 10:978 - 90; http://dx.doi.org/10.1016/j.dnarep.2011.07.005; PMID: 21839691
  • Tan LJ, Saijo M, Kuraoka I, Narita T, Takahata C, Iwai S, Tanaka K. Xerodermapigmentosum group F protein binds to Eg5 and is required for proper mitosis: implications for XP-F and XFE. Genes Cells 2012; 17:173 - 85; http://dx.doi.org/10.1111/j.1365-2443.2012.01582.x; PMID: 22353549
  • Olaussen KA, Dunant A, Fouret P, Brambilla E, André F, Haddad V, Taranchon E, Filipits M, Pirker R, Popper HH, et al, IALT Bio Investigators. DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med 2006; 355:983 - 91; http://dx.doi.org/10.1056/NEJMoa060570; PMID: 16957145
  • Friboulet L, Olaussen KA, Pignon JP, Shepherd FA, Tsao MS, Graziano S, Kratzke R, Douillard JY, Seymour L, Pirker R, et al. ERCC1 isoform expression and DNA repair in non-small-cell lung cancer. N Engl J Med 2013; 368:1101 - 10; http://dx.doi.org/10.1056/NEJMoa1214271; PMID: 23514287
  • Aboussekhra A, Biggerstaff M, Shivji MK, Vilpo JA, Moncollin V, Podust VN, Protić M, Hübscher U, Egly JM, Wood RD. Mammalian DNA nucleotide excision repair reconstituted with purified protein components. Cell 1995; 80:859 - 68; http://dx.doi.org/10.1016/0092-8674(95)90289-9; PMID: 7697716
  • Arora S, Kothandapani A, Tillison K, Kalman-Maltese V, Patrick SM. Downregulation of XPF-ERCC1 enhances cisplatin efficacy in cancer cells. DNA Repair (Amst) 2010; 9:745 - 53; http://dx.doi.org/10.1016/j.dnarep.2010.03.010; PMID: 20418188
  • Weeda G, Donker I, de Wit J, Morreau H, Janssens R, Vissers CJ, Nigg A, van Steeg H, Bootsma D, Hoeijmakers JH. Disruption of mouse ERCC1 results in a novel repair syndrome with growth failure, nuclear abnormalities and senescence. CurrBiol 1997; 7:427 - 39; http://dx.doi.org/10.1016/S0960-9822(06)00190-4; PMID: 9197240
  • Melton DW, Ketchen AM, Núñez F, Bonatti-Abbondandolo S, Abbondandolo A, Squires S, Johnson RT. Cells from ERCC1-deficient mice show increased genome instability and a reduced frequency of S-phase-dependent illegitimate chromosome exchange but a normal frequency of homologous recombination. J Cell Sci 1998; 111:395 - 404; PMID: 9427687
  • Chipchase MD, Melton DW. The formation of UV-induced chromosome aberrations involves ERCC1 and XPF but not other nucleotide excision repair genes. DNA Repair (Amst) 2002; 1:335 - 40; http://dx.doi.org/10.1016/S1568-7864(02)00010-1; PMID: 12509251
  • Vinciguerra P, Godinho SA, Parmar K, Pellman D, D’Andrea AD. Cytokinesis failure occurs in Fanconi anemia pathway-deficient murine and human bone marrow hematopoietic cells. J Clin Invest 2010; 120:3834 - 42; http://dx.doi.org/10.1172/JCI43391; PMID: 20921626
  • Naim V, Rosselli F. The FANC pathway and BLM collaborate during mitosis to prevent micro-nucleation and chromosome abnormalities. Nat Cell Biol 2009; 11:761 - 8; http://dx.doi.org/10.1038/ncb1883; PMID: 19465921
  • Chan KL, Palmai-Pallag T, Ying S, Hickson ID. Replication stress induces sister-chromatid bridging at fragile site loci in mitosis. Nat Cell Biol 2009; 11:753 - 60; http://dx.doi.org/10.1038/ncb1882; PMID: 19465922
  • Dabholkar M, Vionnet J, Parker R, Bostickbruton F, Dobbins A, Reed E. Expression of an alternatively spliced ercc1 messenger-RNA species, is related to reduced DNA-repair efficiency in human T-lymphocytes. Oncol Rep 1995; 2:209 - 14; PMID: 21597714
  • Yu JJ, Mu C, Dabholkar M, Guo Y, Bostick-Bruton F, Reed E. Alternative splicing of ERCC1 and cisplatin-DNA adduct repair in human tumor cell lines. Int J Mol Med 1998; 1:617 - 20; PMID: 9852275
  • Sun Y, Li T, Ma K, Tian Z, Zhu Y, Chen F, Hu G. The impacts of ERCC1 gene exon VIII alternative splicing on cisplatin-resistance in ovarian cancer cells. Cancer Invest 2009; 27:891 - 7; http://dx.doi.org/10.3109/07357900902744536; PMID: 19832035
  • Sijbers AM, van der Spek PJ, Odijk H, van den Berg J, van Duin M, Westerveld A, Jaspers NG, Bootsma D, Hoeijmakers JH. Mutational analysis of the human nucleotide excision repair gene ERCC1. Nucleic Acids Res 1996; 24:3370 - 80; http://dx.doi.org/10.1093/nar/24.17.3370; PMID: 8811092
  • Naim V, Wilhelm T, Debatisse M, Rosselli F. ERCC1 and MUS81-EME1 promote sister chromatid separation by processing late replication intermediates at common fragile sites during mitosis. Nat Cell Biol 2013; 15:1008 - 15; http://dx.doi.org/10.1038/ncb2793; PMID: 23811686

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.